Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-282
Closed -$697 7988
2025
Q2
$697 Buy
+282
New +$654 ﹤0.01% 7278
2024
Q1
Sell
-377
Closed -$2.8K 7385
2023
Q4
$2.8K Sell
377
-1,072
-74% -$9.15K ﹤0.01% 6402
2023
Q3
$14.7K Buy
1,449
+255
+21% +$5.42K ﹤0.01% 5721
2023
Q2
$25K Buy
+1,194
New +$24.4K ﹤0.01% 5419

Osaic Holdings's SLRN Position: Q3 2025 in Review

Osaic Holdings sold out of ACELYRIN (SLRN) in Q3 2025, closing a stake of 282 shares — an estimated $697 sold.

Osaic Holdings first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $25K in Q2 2023. 0 funds tracked by Wall St. Rank hold SLRN as of Q3 2025.

  • Osaic Holdings reported no remaining ACELYRIN position as of Q3 2025 after selling out during the quarter.
  • Osaic Holdings sold 282 ACELYRIN shares in Q3 2025, an estimated $697.
  • Osaic Holdings first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
  • Osaic Holdings's ACELYRIN position peaked at $25K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held ACELYRIN as of Q3 2025.

Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.